Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma

Nav

General Info

Geography

China (CHN)

Shaanxi

Coverage type

Subnational

Time period covered

01/2011 - 12/2013

Data type

Scientific literature

Keywords

Cirrhosis of the liver

Citation

Authors

Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX

Journal

Oncol Rep

Volume

Issue

Pages

1550-6

Publication year

2014

Suggested citation

Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Oncol Rep. 2014; 32(4): 1550-6.

GHDx Entry last modified on: Oct 23, 2024

Header sites

Search form

Main menu

Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma

Nav